Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Karl Ziegelbauer. (1998) A dual labelling method for measuring uptake of low molecular weight compounds into the pathogenic yeast Candida albicans. Medical Mycology 36:5, pages 323-330.
Read now
Read now
S. Ansari, P. Gupta, S.K. Mahanty & R. Prasad. (1993) The uptake of amino acids by erg mutants of Candida albicans. Journal of Medical and Veterinary Mycology 31:5, pages 377-386.
Read now
Read now
Articles from other publishers (24)
Matthew McCarthy, Elizabeth M. O’Shaughnessy & Thomas J. Walsh. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
387
395
.
Elizabeth M. O'Shaughnessy, Caron A. Lyman & Thomas J. Walsh. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
295
305
.
N. Mishra, T. Prasad, N. Sharma, R. Prasad & D. Gupta. (2007)
Membrane fluidity and lipid composition in clinical isolates of
Candida albicans
isolated from AIDS/HIV patients
. Acta Microbiologica et Immunologica Hungarica 54:4, pages 367-377.
Crossref
Crossref
Khalid Islam & Stephen Hawser. 2005. Biofilms, Infection, and Antimicrobial Therapy. Biofilms, Infection, and Antimicrobial Therapy
171
184
.
Ritu Pasrija, Shankarling Krishnamurthy, Tulika Prasad, Joachim F. Ernst & Rajendra Prasad. (2005) Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. Journal of Antimicrobial Chemotherapy 55:6, pages 905-913.
Crossref
Crossref
Philip S. Stewart, Pranab K. Mukherjee & Mahmoud A. Ghannoum. 2004. Microbial Biofilms. Microbial Biofilms
250
268
.
Siegfried Salomon, Angelika Felk & Wilhelm Schäfer. 2004. Fungal Genomics. Fungal Genomics
99
135
.
Pranab K. Mukherjee, Jyotsna Chandra, Duncan M. Kuhn & Mahmoud A. Ghannoum. (2003)
Mechanism of Fluconazole Resistance in
Candida albicans
Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols
. Infection and Immunity 71:8, pages 4333-4340.
Crossref
Crossref
Kasturi Mukhopadhyay, Avmeet Kohli & Rajendra Prasad. (2002) Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition. Antimicrobial Agents and Chemotherapy 46:12, pages 3695-3705.
Crossref
Crossref
Elias K. Manavathu, Jonathan R. Dimmock, Sarvesh C. Vashishtha & Pranatharthi H. Chandrasekar. (1999) Proton-Pumping-ATPase-Targeted Antifungal Activity of a Novel Conjugated Styryl Ketone. Antimicrobial Agents and Chemotherapy 43:12, pages 2950-2959.
Crossref
Crossref
Patrick Marichal, Luc Koymans, Staf Willemsens, Danny Bellens, Peter Verhasselt, Walter Luyten, Marcel Borgers, Frans C. S. Ramaekers, Frank C. Odds & Hugo Vanden Bossche. (1999) Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145:10, pages 2701-2713.
Crossref
Crossref
Karl Ziegelbauer. (1998) Decreased Accumulation or Increased Isoleucyl-tRNA Synthetase Activity Confers Resistance to the Cyclic β-Amino Acid BAY 10-8888 in Candida albicans and Candida tropicalis. Antimicrobial Agents and Chemotherapy 42:7, pages 1581-1586.
Crossref
Crossref
María Luisa Hernáez, Concha Gil, Jesús Pla & César Nombela. (1998) Induced expression of theCandida albicans multidrug resistance geneCDR1 in response to fluconazole and other antifungals. Yeast 14:6, pages 517-526.
Crossref
Crossref
Theodore C. White, Kieren A. Marr & Raleigh A. Bowden. (1998) Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clinical Microbiology Reviews 11:2, pages 382-402.
Crossref
Crossref
J. PLA, C. GIL, L. MONTEOLIVA, F. NAVARRO-GARCÍA, M. SÁNCHEZ & C. NOMBELA. (1996) UnderstandingCandida albicans at the Molecular Level. Yeast 12:16, pages 1677-1702.
Crossref
Crossref
D SanglardK KuchlerF IscherJ L PaganiM MonodJ Bille. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and Chemotherapy 39:11, pages 2378-2386.
Crossref
Crossref
H M WardleD LawC B MooreC MasonD W Denning. (1995) In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrobial Agents and Chemotherapy 39:4, pages 868-871.
Crossref
Crossref
M A GhannoumB J SpellbergA S IbrahimJ A RitchieB CurrieE D SpitzerJ E EdwardsJrJrA Casadevall. (1994) Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrobial Agents and Chemotherapy 38:9, pages 2029-2033.
Crossref
Crossref
J H RexM A PfallerM G RinaldiA PolakJ N Galgiani. (1993) Antifungal susceptibility testing. Clinical Microbiology Reviews 6:4, pages 367-381.
Crossref
Crossref
C A HitchcockG W PyeP F TrokeE M JohnsonD W Warnock. (1993) Fluconazole resistance in Candida glabrata. Antimicrobial Agents and Chemotherapy 37:9, pages 1962-1965.
Crossref
Crossref
Prashant Mishra, J. Bolard & Rajendra Prasad. (1992) Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1127:1, pages 1-14.
Crossref
Crossref
P. Mishra & R. Prasad. 1991. Candida Albicans. Candida Albicans
128
143
.
Prashant Mishra & Rajendra Prasad. (1990) An overview of lipids of Candida albicans. Progress in Lipid Research 29:2, pages 65-85.
Crossref
Crossref
Michael A. Gealt, Abbas Abdollahi & Joseph L. Evans. 1989. Current Topics in Medical Mycology. Current Topics in Medical Mycology
218
247
.